These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 221163

  • 1. [Hormone receptors and breast carcinoma].
    Maass H, Jonat W.
    Dtsch Med Wochenschr; 1979 Jun 22; 104(25):893-4. PubMed ID: 221163
    [Abstract] [Full Text] [Related]

  • 2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC.
    Cancer Res; 1979 May 22; 39(5):1447-54. PubMed ID: 427788
    [Abstract] [Full Text] [Related]

  • 3. Steroid receptors in breast cancer.
    Desombre ER.
    Monogr Pathol; 1984 May 22; (25):149-74. PubMed ID: 6377047
    [Abstract] [Full Text] [Related]

  • 4. [The clinical significance of hormone receptors in the treatment of breast cancer].
    Trams G.
    Fortschr Med; 1979 Apr 12; 97(14):641-4. PubMed ID: 437632
    [Abstract] [Full Text] [Related]

  • 5. [Steroid hormone receptors in breast carcinoma].
    Klinga K, Kaufmann M, Runnebaum B, Kubli F.
    Dtsch Med Wochenschr; 1982 Feb 26; 107(8):313-5. PubMed ID: 6277591
    [No Abstract] [Full Text] [Related]

  • 6. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment.
    Søreide JA, Lea OA, Varhaug JE, Skarstein A, Kvinnsland S.
    Eur J Surg Oncol; 1992 Apr 26; 18(2):112-8. PubMed ID: 1582503
    [Abstract] [Full Text] [Related]

  • 7. [Effect of morphological parameters on steroid hormone receptor concentration in breast cancer].
    Torhorst J, Roos W, Takahashi A, Eppenberger U.
    Geburtshilfe Frauenheilkd; 1984 May 26; 44(5):300-3. PubMed ID: 6088354
    [Abstract] [Full Text] [Related]

  • 8. [Hormone receptor analysis and cytostatic agent sensitivity testing. Significance in additional therapy planning of breast carcinoma].
    Schlag P, Schreml W, Veser J, Herfarth C.
    Dtsch Med Wochenschr; 1981 Dec 25; 106(51-52):1749-54. PubMed ID: 6276119
    [No Abstract] [Full Text] [Related]

  • 9. [Current approaches to hormonal therapy of breast cancer in men].
    Letiagin VP, Makarenko NP, Koposova TL.
    Ter Arkh; 1984 Dec 25; 56(9):122-4. PubMed ID: 6096980
    [Abstract] [Full Text] [Related]

  • 10. Association between steroid hormone receptor status and disease-free interval in breast cancer.
    Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HM, Aitken SC, Warren R.
    Cancer Treat Rep; 1979 Aug 25; 63(8):1271-7. PubMed ID: 476705
    [Abstract] [Full Text] [Related]

  • 11. [Intratumoral regional differences in hormone receptor status of breast cancer].
    Locher GW, Davis B, Zava DT, Goldhirsch A, Hartmann WH.
    Geburtshilfe Frauenheilkd; 1984 May 25; 44(5):304-6. PubMed ID: 6088355
    [Abstract] [Full Text] [Related]

  • 12. [The importance of hormone receptor analysis for diagnosis and therapy of gynecologic malignancies].
    Gitsch E, Salzer H.
    Wien Klin Wochenschr; 1983 May 27; 95(11):385-8. PubMed ID: 6310902
    [Abstract] [Full Text] [Related]

  • 13. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
    Osborne CK, McGuire WL.
    Bull Cancer; 1979 May 27; 66(3):203-9. PubMed ID: 385079
    [Abstract] [Full Text] [Related]

  • 14. Improved measurement of androgen receptors in human breast cancer.
    Lea OA, Kvinnsland S, Thorsen T.
    Cancer Res; 1989 Dec 15; 49(24 Pt 1):7162-7. PubMed ID: 2582456
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Hormone therapy of breast cancer].
    Maass H.
    Med Welt; 1976 May 21; 27(21):1047-51. PubMed ID: 180375
    [Abstract] [Full Text] [Related]

  • 17. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB, Nikolić-Vukosavljević DB, Branković-Magić MV, Mitrovic LB, Spuzić I.
    Neoplasma; 2000 May 21; 47(2):107-13. PubMed ID: 10985476
    [Abstract] [Full Text] [Related]

  • 18. [Hormone receptors in breast cancer].
    Navarra S, Melita P, Di Mauro S, Calbo L, Belnome N.
    Minerva Med; 1981 May 19; 72(20):1277-82. PubMed ID: 6264354
    [Abstract] [Full Text] [Related]

  • 19. Trepanobiopsy as a tool for the study of the influence of presurgical treatment on the steroid receptor status of advanced breast cancer.
    Bassalyk LS, Koposova TL, Muravyeva NI, Smirnova KD, Kuzmina ZV, Gershtein ES, Letyagin VP.
    Neoplasma; 1986 May 19; 33(2):245-50. PubMed ID: 3713927
    [Abstract] [Full Text] [Related]

  • 20. [Endocrine therapy only in hormone-receptor-positive breast neoplasms].
    Bohnet HG, Weber H.
    Med Klin; 1980 Nov 07; 75(23):818-22. PubMed ID: 6255300
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.